Exact Sciences Corp (NAS:EXAS)
$ 49.84 -4.24 (-7.84%) Market Cap: 9.20 Bil Enterprise Value: 11.10 Bil PE Ratio: 0 PB Ratio: 2.93 GF Score: 80/100

Exact Sciences Corp at Raymond James Institutional Investors Conference Transcript

Mar 07, 2023 / 09:00PM GMT
Release Date Price: $66.08 (-1.42%)
Andrew Harris Cooper
Raymond James & Associates, Inc., Research Division - Research Analyst

Good afternoon, everybody. Welcome to -- or thanks for joining us at the Raymond James Institutional Investor Conference. We're happy to have folks from Exact Sciences here with us today.

Nobody wants to hear from me. So I'm just going to sit down and give Kevin a little bit of time with some slides. And then I'll join him again for -- and Megan as well, for some Q&A. Kevin?

Kevin T. Conroy
Exact Sciences Corporation - Chairman of The Board & CEO

Thanks for having us at this great conference. We appreciate the opportunity. Exact Sciences is a cancer diagnostic company. We are the leading cancer diagnostic company at a time that is a very innovative time in the field that's having a huge impact on patient lives.

And our goal as a company is to move detection from late stage to early stage, and we'll talk about the impact. This is our safe harbor. We will be making forward-looking statements. Our mission as a company is to eradicate cancer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot